Cargando…

Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel()

• First case report of successfully treating severe paclitaxel and docetaxel hypersensitivity reaction with nab-paclitaxel; • We demonstrated that nab-paclitaxel is a safe taxane chemotherapy treatment option for patients who could not tolerate paclitaxel or docetaxel.

Detalles Bibliográficos
Autores principales: de Leon, Maria C.B., Bolla, Sridhar, Greene, Barbra, Hutchinson, Lauren, Del Priore, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862232/
https://www.ncbi.nlm.nih.gov/pubmed/24371703
http://dx.doi.org/10.1016/j.gynor.2013.05.003
_version_ 1782295723951259648
author de Leon, Maria C.B.
Bolla, Sridhar
Greene, Barbra
Hutchinson, Lauren
Del Priore, Giuseppe
author_facet de Leon, Maria C.B.
Bolla, Sridhar
Greene, Barbra
Hutchinson, Lauren
Del Priore, Giuseppe
author_sort de Leon, Maria C.B.
collection PubMed
description • First case report of successfully treating severe paclitaxel and docetaxel hypersensitivity reaction with nab-paclitaxel; • We demonstrated that nab-paclitaxel is a safe taxane chemotherapy treatment option for patients who could not tolerate paclitaxel or docetaxel.
format Online
Article
Text
id pubmed-3862232
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-38622322013-12-26 Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel() de Leon, Maria C.B. Bolla, Sridhar Greene, Barbra Hutchinson, Lauren Del Priore, Giuseppe Gynecol Oncol Case Rep Case Report • First case report of successfully treating severe paclitaxel and docetaxel hypersensitivity reaction with nab-paclitaxel; • We demonstrated that nab-paclitaxel is a safe taxane chemotherapy treatment option for patients who could not tolerate paclitaxel or docetaxel. Elsevier 2013-05-14 /pmc/articles/PMC3862232/ /pubmed/24371703 http://dx.doi.org/10.1016/j.gynor.2013.05.003 Text en © 2013 The Authors http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Case Report
de Leon, Maria C.B.
Bolla, Sridhar
Greene, Barbra
Hutchinson, Lauren
Del Priore, Giuseppe
Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel()
title Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel()
title_full Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel()
title_fullStr Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel()
title_full_unstemmed Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel()
title_short Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel()
title_sort successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel()
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862232/
https://www.ncbi.nlm.nih.gov/pubmed/24371703
http://dx.doi.org/10.1016/j.gynor.2013.05.003
work_keys_str_mv AT deleonmariacb successfultreatmentwithnabpaclitaxelafterhypersensitivityreactiontopaclitaxelanddocetaxel
AT bollasridhar successfultreatmentwithnabpaclitaxelafterhypersensitivityreactiontopaclitaxelanddocetaxel
AT greenebarbra successfultreatmentwithnabpaclitaxelafterhypersensitivityreactiontopaclitaxelanddocetaxel
AT hutchinsonlauren successfultreatmentwithnabpaclitaxelafterhypersensitivityreactiontopaclitaxelanddocetaxel
AT delprioregiuseppe successfultreatmentwithnabpaclitaxelafterhypersensitivityreactiontopaclitaxelanddocetaxel